rac-(R*)-α-[3-[[2-(3,4-ジメトキシフェニル)エチル]メチルアミノ]プロピル]-3,4-ジメトキシ-α-(1-メチルエチル)ベンゼンアセトニトリル/塩酸,(1:1)
rac-(R*)-α-[3-[[2-(3,4-ジメトキシフェニル)エチル]メチルアミノ]プロピル]-3,4-ジメトキシ-α-(1-メチルエチル)ベンゼンアセトニトリル/塩酸,(1:1) 物理性質
安全性情報
rac-(R*)-α-[3-[[2-(3,4-ジメトキシフェニル)エチル]メチルアミノ]プロピル]-3,4-ジメトキシ-α-(1-メチルエチル)ベンゼンアセトニトリル/塩酸,(1:1) 価格
メーカー |
製品番号 |
製品説明 |
CAS番号 |
包装 |
価格 |
更新時間 |
購入 |
rac-(R*)-α-[3-[[2-(3,4-ジメトキシフェニル)エチル]メチルアミノ]プロピル]-3,4-ジメトキシ-α-(1-メチルエチル)ベンゼンアセトニトリル/塩酸,(1:1) 化学特性,用途語,生産方法
化学的特性
White Powder
使用
A calcium channel blocker. Antihypertensive; antianginal; antiarrhythmic (class IV)
純化方法
The salt is purified by dissolving it in EtOH, filtering (if insoluble particles are present) and adding Et2O, filtering the salt, washing it with Et2O and drying it in vacuo. It has the following solubilities: hexane (0.001%), CH2Cl2 (~10%), MeOH (~10%), EtOH (20%) and H2O (8.3%). It has UV max at 232 and 278nm. The free base is a viscous yellow oil b 243-246o/0.01mm (n 25D 1.5448) and is almost insoluble in H2O but soluble in organic solvents. It is a Ca channel antagonist and is a coronary vasodilator. [Ramuz Helv Chim Acta 58 2050 1975, Harvey et al. Biochem J 257 95 1989.]
rac-(R*)-α-[3-[[2-(3,4-ジメトキシフェニル)エチル]メチルアミノ]プロピル]-3,4-ジメトキシ-α-(1-メチルエチル)ベンゼンアセトニトリル/塩酸,(1:1) 上流と下流の製品情報
原材料
準備製品
rac-(R*)-α-[3-[[2-(3,4-ジメトキシフェニル)エチル]メチルアミノ]プロピル]-3,4-ジメトキシ-α-(1-メチルエチル)ベンゼンアセトニトリル/塩酸,(1:1) 生産企業
Global( 150)Suppliers
23313-68-0(rac-(R*)-α-[3-[[2-(3,4-ジメトキシフェニル)エチル]メチルアミノ]プロピル]-3,4-ジメトキシ-α-(1-メチルエチル)ベンゼンアセトニトリル/塩酸,(1:1))キーワード:
- 23313-68-0
- CALAN
- IPROVERATRIL
- (+/-)-5-[N-(3,4-DIMETHOXYPHENYLETHYL)-METHYLAMINO]-2-(3,4-DIMETHOXYPHENYL)-2-ISOPROPYLVALERONITRILE HYDROCHLORIDE
- 5-[N-(3,4-DIMETHOXYPHENYLETHYL)METHYLAMINO]-2-(3,4-DIMETHOXYPHENYL)-2-ISOPROPYLVALERONITRILE HYDROCHLORIDE
- alpha-(3-((2-(3,4-dimethoxyphenyl)ethyl)methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)-benzeneacetonitrile hydrochloride
- ALPHA-[3-[[2-(3,4-DIMETHOXYPHENYL)ETHYL]METHYLAMINO]PROPYL]-3,4-DIMETHOXY-ALPHA-(1-METHYLETHYL)BENZENEACETONITRILE HYDROCHLORIDE
- 5-[(3,4-DIMETHOXYPHENETHYL)METHYLAMINO]-2-(3,4-DIMETHOXYPHENYL)-2-ISOPROPYL-VALERONITRILE HYDROCHLORIDE
- (+/-)-VERAPAMIL HYDROCHLORIDE
- VERAPAMIL HYDROCHLORIDE
- VERAPAMIL HCL
- ISOPTIN
- a-[3-[[2-(3,4-Dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-a-(1-methylethyl)-benzeneacetonitrile Hydrochloride
- Berkatens
- Cardibeltin
- Dignover
- Veracim
- Veramex
- Zolvera
- (±)-[3-cyano-3-(3,4-dimethoxyphenyl)hex-6-yl](5,6-dimethoxyphenethyl)methylammonium chloride
- dl-Verapamil hydrochloride
- alpha-[3-[[2-(3,4-Dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-alpha(1-methylethyl)benzeneacetonitrile monohydrochloride
- 5-((3,4-diMethoxyphenethyl)(Methyl)aMino)-2-(3,4-diMethoxyphenyl)-2-isopropylpentanenitrile hydrochloride
- Verapamil hydrochloride USP/EP/BP
- 塩酸(±)-ベラパミル
- rac-(R*)-α-[3-[[2-(3,4-ジメトキシフェニル)エチル]メチルアミノ]プロピル]-3,4-ジメトキシ-α-(1-メチルエチル)ベンゼンアセトニトリル/塩酸,(1:1)
- rac-(αR*)-α-[3-[[2-(3,4-ジメトキシフェニル)エチル](メチル)アミノ]プロピル]-3,4-ジメトキシ-α-(1-メチルエチル)ベンゼンアセトニトリル/塩酸,(1:1)
- (±)-ベラパミル塩酸塩
- dl-ベラパミル塩酸塩
- 酸ベラパミル